SHALBY145.25

Shalby Limited

· Pharma & Health
₹ CrorePeersGKSLGPTHEALTHINDRAMEDCOARTEMISMEDLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹1,562 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SHALBY
FY26
GKSL
FY26
GPTHEALTH
FY26
INDRAMEDCO
FY26
Peer
Median
Valuation — at last close
P/E44.97×69.84×31.27×18.00×31.27× +44%
P/B1.55×5.38×4.90×4.46×4.90× -68%
EV/EBITDA14.13×50.98×15.33×12.36×15.33× -8%
Market Cap₹1,562 Cr₹1,371 Cr₹1,322 Cr₹3,305 Cr₹1,371 Cr +14%
Growth
Revenue CAGR 3Y12.35%10.50%10.50% +18%
Revenue CAGR 5Y19.30%19.30%
Net Income CAGR 3Y-19.97%28.69%28.69% -170%
Revenue YoY (latest Q)11.74%17.83%11.26%14.54% -19%
Net Income YoY (latest Q)36.70%65.73%8.53%37.13% -1%
Profitability
EBITDA Margin12.51%32.85%17.81%18.00%18.00% -31%
Net Income Margin3.04%20.50%8.93%12.39%12.39% -75%
Return on Common Equity3.72%6.08%15.67%24.80%15.67% -76%
Return on Capital Employed5.76%8.24%14.82%27.17%14.82% -61%
Return on Assets1.89%5.65%9.08%18.52%9.08% -79%
Credit & Quality
Total Debt/Equity0.54×0.06×0.06×0.00×0.06× +800%
Interest Coverage1.87×11.84×6.93×37.09×11.84× -84%
Scale — latest FY
Revenue / Total Income₹1,141 Cr₹82 Cr₹473 Cr₹1,483 Cr₹473 Cr +142%
Net Income₹34.7 Cr₹16.8 Cr₹42.2 Cr₹184 Cr₹42.2 Cr -18%
Total Assets₹1,839 Cr₹298 Cr₹465 Cr₹991 Cr₹465 Cr +296%
EPS₹3.23₹2.49₹5.15₹20.03₹5.15 -37%
Book Value per Share₹93.54₹32.31₹32.84₹80.76₹32.84 +185%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.